D-1152-2018 Class II Terminated

Recalled by Pharmcore Inc. — Hallandale Beach, FL

FDA drug recall D-1152-2018 was initiated by Pharmcore Inc. on August 2, 2018 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall status is terminated (terminated January 18, 2022). Affected quantity: 3351 vials.

Recall Details

Product Type
Drugs
Report Date
September 5, 2018
Initiation Date
August 2, 2018
Termination Date
January 18, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3351 vials

Product Description

Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

Nationwide

Code Information

Lots: HCG60122 Exp. 4/30/2019; HCG60124 Exp. 6/30/2019; HCG60121 Exp. 4/30/2019; HCG60123 Exp. 5/31/2019; HCG60120 Exp. 4/30/2019; HCG60118 Exp. 2/28/2019; HCG1115 Exp. 1/31/2019